The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Forecasted Market Value Of The Buccal Drug Delivery System Market Across 2026–2030?
The buccal drug delivery system market size has seen swift expansion in recent times. It is anticipated to increase from $3.89 billion in 2025 to $4.32 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.2%. Several factors contributed to its growth historically, including a rising preference for alternative drug administration methods, an increase in treatments for chronic pain and angina, breakthroughs in mucoadhesive formulations, a greater demand for medications with faster onset, and the broadening of oral pharmaceutical manufacturing.
The buccal drug delivery system market is projected to experience substantial growth over the coming years. This market is forecast to reach $6.48 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.7%. This expansion during the forecast period is driven by factors such as increased investments in transmucosal drug research, a rising need for smoking cessation treatments, the expansion of personalized drug delivery systems, a greater emphasis on formulations that enhance compliance, and the growing development of new buccal drugs. Key trends anticipated within this period involve the increasing embrace of buccal and sublingual dosage forms, a heightened demand for systems that enable rapid drug absorption, an escalating focus on patient-friendly methods for drug delivery, the broadening of controlled-release buccal formulations, and an increased emphasis on non-invasive therapeutic approaches.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8290&type=smp
What Major Growth Drivers Are Shaping The Outlook Of The Buccal Drug Delivery System Market?
The increasing occurrence of chronic illnesses is anticipated to drive the expansion of the buccal drug delivery systems market. Chronic diseases refer to conditions that persist for a year or longer, encompassing ailments such as cancer, heart disease, stroke, diabetes, cancer, and arthritis. These are widely prevalent chronic illnesses that, while manageable and not curable, necessitate continuous nutritional and medical attention. Buccal drug delivery systems provide appropriate and effective drug delivery for administering mucosal and transmucosal drugs required by numerous patients suffering from chronic diseases, including diabetes and cancer. For instance, in June 2024, the National Health Service, a UK-based government department, indicated that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes (a condition with elevated blood sugar levels, not high enough to be classified as diabetes) in 2023, an 18% increase from 3,065,825 cases in 2022. Thus, the growing prevalence of chronic diseases is propelling the growth of the buccal drug delivery systems market.
What Segmentation Levels Are Considered In The Buccal Drug Delivery System Market?
The buccal drug delivery system market covered in this report is segmented –
1) By Type: Sublingual, Buccal Tablets And Lozenges, Oral Sprays
2) By Application: Pain Management, Smoking Cessation, Angina Pectoris
3) By End-User: Hospitals, Ambulatory Centers, Other End-Users
Subsegments:
1) By Sublingual: Sublingual Tablets, Sublingual Films
2) By Buccal Tablets And Lozenges: Buccal Tablets, Buccal Lozenges
3) By Oral Sprays: Spray Solutions, Spray Gels
What Trends Are Projected To Affect The Buccal Drug Delivery System Market?
Major companies in the buccal drug delivery systems market are concentrating on launching products, such as melatonin oral spray, to increase their revenues. Melatonin oral spray is a form of melatonin supplementation designed as a spray for oral application. For instance, in February 2023, Arlak Biotech Private Limited, an India-based pharmaceutical company, introduced a melatonin oral spray. This spray aids the body’s natural melatonin production, thereby improving sleep quality in an easy and effective manner. The medication offers a rapid solution for individuals who struggle with falling asleep, staying asleep, or adjusting to various sleep patterns. The spray’s fast and simple oral absorption contributes to a quicker onset of sleep and enhanced sleep quality.
Which Leading Firms Are Contributing To The Growth Of The Buccal Drug Delivery System Market?
Major companies operating in the buccal drug delivery system market are Teva Pharmaceuticals Industries Ltd, Pfizer Incorporated, GlaxoSmithKline Public Limited Company, Indivior PLC, Generex Biotechnology Corporation, Catalent Inc, Arx Limited Liability Company, BioDelivery Science International Incorporated, Cynapsus Therapeutics Incorporated, Endo Pharmaceuticals Public Limited Company, Medlab Clinical Ltd, AstraZeneca PLC, Dr. Reddy’s Laboratories Ltd, Takeda Pharmaceutical Company Limited, Novartis AG, Sanofi SA, Bayer AG, Adare Pharmaceuticals Inc, NAPP Pharmaceutical Ltd, Perrigo Company PLC, Reckitt Benckiser Group PLC, Teligent Pharma Inc, Par Pharmaceutical Companies Inc, Acorda Therapeutics Inc, Opiant Pharmaceuticals Inc
Read the full buccal drug delivery system market report here:
https://www.thebusinessresearchcompany.com/report/buccal-drug-delivery-system-global-market-report
Which Regions Are Projected To Dominate The Buccal Drug Delivery System Market In The Coming Years?
North America was the largest region in the buccal drug delivery systems market share in 2025. The regions covered in the buccal drug delivery system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Buccal Drug Delivery System Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=8290&type=smp
Browse Through More Reports Similar to the Global Buccal Drug Delivery System Market 2026, By The Business Research Company
Gastroretentive Drug Delivery Systems Outsourcing Market Report 2026
Pharmaceutical Drug Delivery Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report
Advanced Drug Delivery Systems Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model